base-metals-investing Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference
base-metals-investing Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies
base-metals-investing Cellectar Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update
base-metals-investing Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Thursday, November 13, 2025
base-metals-investing Cellectar Biosciences Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration for Iopofosine I 131 in Relapsed or Refractory Pediatric High-Grade Glioma
base-metals-investing Cellectar Biosciences Presented Promising Preclinical Data in Poster Presentation at the American Association for Cancer Research Special Conference on Pancreatic Cancer Research
base-metals-investing Cellectar Biosciences Presented Compelling Data in Oral Session and Panel Discussions at the American Association for Cancer Research Special Conference on Discovery and Innovation in Pediatric Cancer
base-metals-investing Cellectar and Evestia Clinical Announce Partnership to Support Auger-Emitting Radiopharmaceutical Clinical Trial in Triple-Negative Breast Cancer
base-metals-investing Cellectar Biosciences and ITM Enter Supply Agreement for GMP-Grade Actinium-225
base-metals-investing Cellectar Biosciences to Participate at Oppenheimer 3rd Annual Targeted Radiopharmaceutical Therapies in Oncology Summit
base-metals-investing Cellectar Biosciences to Participate in Multiple Upcoming Medical Meetings and Industry Conferences in September
base-metals-investing Cellectar Biosciences to Present Data in Poster Presentation at the American Association for Cancer Research Special Conference on Advances in Pancreatic Cancer Research
base-metals-investing Cellectar Biosciences to Present Data in Oral Session and Panel Discussions at the American Association for Cancer Research Special Conference on Discovery and Innovation in Pediatric Cancer
